The Pharmacology and Use of H1-Receptor-Antagonist Drugs
- 9 June 1994
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 330 (23) , 1663-1670
- https://doi.org/10.1056/nejm199406093302307
Abstract
The H1-receptor antagonists are among the most widely used medications in the world. We review here the molecular basis of their action and their clinical pharmacology, efficacy in allergic disorders, and adverse effects. Although we will discuss the first-generation, relatively sedating H1-receptor antagonists briefly, we will emphasize the role of the second-generation, relatively nonsedating H1 antagonists (Figure 1) and will identify future directions for research of these agents.Molecular Basis of ActionHistamine mediates a variety of physiologic and pathologic responses in different tissues and cells and is an important chemical mediator of inflammation in . . .Keywords
This publication has 78 references indexed in Scilit:
- H1-Receptor AntagonistsDrug Safety, 1994
- Genomic Cloning, Heterologous Expression and Pharmacological Characterization of a Human Histamine H1 ReceptorBiochemical and Biophysical Research Communications, 1993
- CetirizineDrugs, 1993
- AcrivastineDrugs, 1991
- LevocabastineDrugs, 1991
- KetotifenDrugs, 1990
- Rational Use of Antihistamines in Allergic Dermatological ConditionsDrugs, 1989
- The Pharmacokinetics and Pharmacodynamics of Hydroxyzine in Patients with Primary Biliary CirrhosisThe Journal of Clinical Pharmacology, 1989
- Clinical Pharmacokinetics of H1-Receptor Antagonists (The Antihistamines)Clinical Pharmacokinetics, 1985
- Lack of Efficacy of a Decongestant-Antihistamine Combination for Otitis Media with Effusion (Secretory Otitis Media) in ChildrenNew England Journal of Medicine, 1983